Implementing the 2019 ASCCP Risk-Based Management Guidelines for Abnormal Cervical Cancer Screening Tests in Your Practice

July 23, 2020

The long-awaited new ASCCP Management Guideline App is now available, as well as the print version of the 2019 Guidelines. The new guidelines are streamlined for ease of use and can be significantly more individualized than the 2012 guidance by integrating information about an individual’s previous screening test and biopsy results, and personal factors such as age and immunosuppression. The guidelines now provide recommended follow up for all 3 available cervical screening strategies.

The following topics are covered in detail:

  • The rationale used in developing the Guidelines
  • How various abnormalities should be managed
  • Interactive demonstrations of how to use the app
  • Specific considerations for the application of Family PACT benefits, including coding and billing

Learning objectives: At the end of this session, the learner will be able to:

  1. Describe the risk-based paradigm for managing abnormal cervical cancer screening test results.
  2. Explain how risk-thresholds guide the clinical actions of immediate treatment, colposcopy, and short-interval follow up.
  3. Demonstrate use of the ASCCP app to apply the new guidelines to patient care.

Presenters:

Resources

Clinical Practice Alert: Cervical Cancer Screening and Emergency Contraception

March 24, 2020

This webinar features two new Family PACT Clinical Practice Alerts.

Cervical Cancer Screening

Topics in this portion of the webinar will include benefits through Family PACT that have been expanded to include high-risk HPV-alone screening, use of this test, alternative cervical cancer screening options, and new guidelines regarding cervical cancer screening for females who are HIV positive or who are immunocompromised.

Emergency Contraception

Topics in this portion of the webinar will include the relationship between body weight and emergency contraception failure rates, when oral contraceptives can be started with females who have used ulipristal acetate, options for accessing emergency contraceptive pills and the use of the copper IUD as emergency contraception.

Presenters:

Resources:

Extragenital Screening

Don’t forget to swab! Among men who have sex with men, 84% of gonorrhea and chlamydia infections would be missed with urine-only screening1. Make sure your clients are screened for gonorrhea and chlamydia of the throat and rectum.

3 cotton swabs
What:Extragenital Screening for Gonorrhea and Chlamydia
Where:Rectum and throat
Who:Men who have sex with men (MSM), transgender women, people living with HIV, and people on PrEP who report having receptive anal and/or oral sex
When:At least annually, or every 3 to 6 months as needed based on exposure
Why:  When urine-only screening is performed, up to 90% of rectal gonorrhea and 77% of rectal chlamydia infections remain untreated1. HIV-negative men diagnosed with rectal infections are excellent candidates for PrEP, because they have a high risk of HIV infection
How: Swab specimen (self or clinician-collected swab)

The California Prevention Training Center supports clinics and providers in implementing rectal and pharyngeal STI screening.

For more information, contact us.

  1. Marcus JL, Bernstein KT, Kohn RP, Liska S, Philip SS. Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sexually transmitted diseases. 2011 Oct 1;38(10):922-4.

The Evolving Well Woman Visit

April 26, 2018

The contents of the well-woman visit have changed significantly in the past decade, such that many screening tests are performed in modified age groups and at different screening intervals. This webinar will review the well-woman health screening recommendations published by the California Department of Public Health (CDPH), U.S. Preventive Services Task Force (USPSTF), American College of Obstetrics and Gynecology (ACOG) and other national organizations.

The following topics are covered in detail:

  • Reproductive goals counseling
  • Use of newer cervical cancer screening technologies
  • Utility of screening clinical breast exams and screening pelvic exams
  • Coding for well-woman visits

Presenter:

Resources: